No Data
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Rodman & Renshaw Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $12
Rodman & Renshaw Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $12
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Achieve Life Sciences Poised for U.S. Launch of Cytisinicline With Strong Financial and Strategic Foundations
No Data
No Data